Revision of Pluri Inc.
mediawikibotAB-V1Rendered
Pluristem Therapeutics is an Israeli company engaged in the development of human placental adherent stromal cells for commercial use in disease treatment. According to the company's website, it extracts adult stem cells exclusively from postnatal placentas. from Wikipedia
An Israeli company engaged in the development of human placental adherent stromal cells for commercial use.
Wikitext diff vs parent
{{DISPLAYTITLE:Pluristem Therapeutics}} Pluristem Therapeutics is an Israeli company engaged in the development of human placental adherent stromal cells for commercial use in disease treatment. According to the company's website, it extracts adult stem cells exclusively from postnatal placentas.<small> from [https://en.wikipedia.org/wiki/Pluristem_Therapeutics Wikipedia]</small>{{SF| {{Twt|pluristem}} {{Wb|http://www.pluristem.com/|pluristem.com}} {{Fb|Pluristem}} {{Yt|UC65WAbsbyKFNqvWWkfWZkKQ|Pluristem Therapeutics}} }}{{IDF|{{Wd|Q7205567}}}}{{VHID|89879688987}}{{#subtitle: <big>An Israeli company engaged in the development of human placental adherent stromal cells for commercial use.</big>}}